Highland Capital Management, LLC Exact Sciences Corp Transaction History

Highland Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	SELL	$59.06 - $75.72 $7,854 - $10,070	-133 Reduced 0.55%	23,937 $1.77 Million
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $24,991 - $37,536	-379 Reduced 1.55%	24,070 $1.64 Million
Q2 2023 Aug 09, 2023	BUY	$62.68 - $95.05 $1.53 Million - $2.32 Million	24,449 New	24,449 $2.3 Million
Q2 2022 Jul 14, 2022	SELL	$35.61 - $76.23 $713,019 - $1.53 Million	-20,023 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$57.56 - $82.54 $7,770 - $11,142	135 Added 0.68%	20,023 $1.4 Million
Q4 2021 Jan 28, 2022	BUY	$72.5 - $100.68 $1.44 Million - $2 Million	19,888 New	19,888 $1.55 Million

667

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.91B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Highland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highland Capital Management, LLC with notifications on news.